Acumen Pharmaceuticals

Acumen Pharmaceuticals(ABOS)

NEWTON, MA
Pharmaceutical5 H-1B visas (FY2023)
WebsiteLinkedInCareers Page

Focus: Alzheimer’s targeting antibody

Acumen Pharmaceuticals is a life sciences company focused on Alzheimer’s targeting antibody.

Neurology
Funding Stage
PUBLIC
Employees
1-50
Open Jobs
1

Pipeline & Clinical Trials

Phase 1
Clinical Trials (1)
NCT04931459A Study to Evaluate the Safety, Tolerability, and Blood Levels of ACU193 in Participants With MCI or Mild AD
Phase 1
Phase 1
Clinical Trials (1)
NCT06511570A Study Comparing the Safety, Tolerability, and Pharmacokinetics of Sabirnetug IV and Sabirnetug + rHuPH20 SC in Healthy Participants
Phase 1
Phase 2
Clinical Trials (1)
NCT06335173A Study to Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants With Early Alzheimer's Disease (ALTITUDE-AD)
Phase 2

Open Jobs (1)

Associate Director/Director, Clinical Trial Management

Newton, Massachusetts
Clinical Operations
2w ago
Interview Prep Quick Facts
Founded: 2024
Portfolio: 3 clinical trials
H-1B (2023): 5 approvals
SEC Filings: 2 available
Open Roles: 1 active job

Financials (FY2024)

R&D Spend
$42M31%
Net Income
-$52M
Cash
$67M
Source: SEC 10-K Filing

Hiring Trend

Stable
1
Open Roles
+0
Added
-0
Filled/Removed

Based on last 4 crawl cycles

Visa Sponsorship

Sponsors Work Visas
H-1B Petitions (FY2023)
5
Approved
0
Denied
100%
Rate

Source: USCIS H-1B Employer Data Hub